FDA's Eased Oversight Is Good Omen For Health IT

Law360, New York (January 21, 2015, 6:05 PM EST) -- New guidances from the U.S. Food and Drug Administration ease regulatory hurdles for low-risk medical devices in important ways and bode well for looming decisions on how strictly to police next-generation health information technology, experts say.

The two guidances, which were unveiled Friday, apply to medical device accessories and "wellness" products that support healthy lifestyles. The documents explained how products in the respective categories will be evaluated to determine how much oversight is appropriate, and they joined a string of FDA actions over the past couple of years to ease oversight of nontraditional wares in the health IT space.

"They're both positive,"...

Stay ahead of the curve

In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.


  • Access to case data within articles (numbers, filings, courts, nature of suit, and more.)
  • Access to attached documents such as briefs, petitions, complaints, decisions, motions, etc.
  • Create custom alerts for specific article and case topics and so much more!

TRY LAW360 FREE FOR SEVEN DAYS

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Ask a question!